Salute e Benessere

Anal Cancer Market to Showcase Growth at a CAGR of 18% by 2034 | DelveInsight

Key Takeaways from the Anal Cancer Market Report Key Takeaways from the Anal Cancer Market Report Discover which therapies are expected to grab the major anal cancer market share @Anal Cancer Market Report Anal Cancer Overview Anal cancer, although rare, represents approximately 2.5% of gastrointestinal tumors. Nevertheless, its frequency has been progressively rising over the last three to four decades. The rectum and anal canal are interconnected structurally: the rectum...
PR Newswire
29/05/2024

Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive…

"We are encouraged by the positive results of the ZERO-1 study, which highlight the efficacy and safety of JAQBO for patients with erosive esophagitis," said John Kim, Ph.D., CEO of Onconic Therapeutics. "The recent approval by the MFDS of Korea is a significant milestone for Onconic Therapeutics. We are hopeful that JAQBO can improve patient care globally by providing rapid and sustained relief from symptoms, and we are committed to pursuing its development for broader…
PR Newswire
29/05/2024

Curium Extends Irradiation Partnership With NRG I PALLAS in Netherlands for…

The extension of the partnership will further strengthen Curium's plan to benefit more than 100,000 critically ill patients worldwide over the next five years. The HFR reactor has been a pillar of the world's patient access to molybdenum-99 (Mo-99) over the past 40+ years, and more recently for Lu-177. By accessing capacity at HFR for Lu-177, Curium will be able to reliably serve patient demand throughout most of the year at high capacity and importantly will address the growing need for...
Nasdaq GlobeNewswire
29/05/2024

Resolution Therapeutics Announces Upcoming Scientific Presentations at EASL…

EDINBURGH, Scotland and LONDON, May 29, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering engineered autologous macrophage cell therapies to transform the treatment of inflammatory organ diseases, today announces two abstracts have been accepted as poster presentations at the European Association for the Study of the Liver (EASL) Congress 2024, which is being held in Milan, Italy between…
PR Newswire
29/05/2024

Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further…

Michael Pehl, Chief Executive Officer of Adcendo, said: "This financing underscores the confidence that our investors have in Adcendo's capabilities and potential to develop highly innovative ADC cancer therapies to provide treatment options for cancer patients with high unmet medical needs. We are extremely pleased to welcome Iyona to the Adcendo Board of Directors, as she brings a wealth of experience in supporting and advancing early and clinical stage biotech companies." Michael…
PR Newswire
29/05/2024

Sedana Medical completes patient recruitment for its clinical program in the US

Peter Sackey further elaborated: "We now enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months are being collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results for the 30-day outcomes in both studies a few months´ apart before the end of this year, and a swift…
PR Newswire
29/05/2024

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology…

CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells.Control of the amount and stoichiometry of RNP complexes could boost efficiency, particularly when targeting multiple loci simultaneously.Demonstrated preservation of general cell characteristics and functionality post-editing in both single and multiple KO clones in CHO-K1 cells.GLATTBRUGG, Switzerland, May29, 2024(GLOBE NEWSWIRE) --...
Nasdaq GlobeNewswire
29/05/2024

SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier…

Nevisense and the eBarrier Score utilize AI-generated algorithms that researchers can use to directly quantitate the severity of skin barrier dysfunction related to common skin disorders. Nevisense and the eBarrier Score utilize AI-generated algorithms that researchers can use to directly quantitate the severity of skin barrier dysfunction related to common skin disorders. In a recently published study (Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by...
PR Newswire
29/05/2024

BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development

Martin Olin, Chief Executive Officer of BerGenBio stated: Martin Olin, Chief Executive Officer of BerGenBio stated: "1L NSCLC STK11m patients are not currently eligible for targeted therapy and face a very poor prognosis. The total market for this patient group is estimated to be between 4 and5 billion USD. The initiation of Phase 2a of the study of our lead compound bemcentinib in these patients represents an important milestone for the company. Our clinical progress in the quarter...
PR Newswire
29/05/2024

Join Badael and Sign the Pledge for a Smoke-Free Saudi Arabia

In its first year, Badael achieved significant milestones, establishing and expanding its manufacturing capacity while investing substantially in research and development to enhance its product offering. The company has diversified its distribution channels, reaching a notable milestone of surpassing one million e-commerce orders since its inception – and helping around three hundred thousand people locally transition from tobacco. These achievements are a testament to Badael's commitment to…
PR Newswire
29/05/2024

FDA grants Priority Review to Roche's inavolisib for advanced hormone…

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options 1,2 Additional analyses of INAVO120 will be presented in an oral abstract session at the 2024 American Society of Clinical Oncology Annual MeetingThe target action date for the FDA decision is 27 November, 2024Basel, 29 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has...
Nasdaq GlobeNewswire
29/05/2024

Information on the Total Number of Voting Rights and Shares

REGULATED INFORMATIONInformation on the Total Number of Voting Rights and SharesMont-Saint-Guibert (Belgium), May 28, 2024, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,851,253.43 Total number of securities carrying voting rights: 34,060,390 (all ordinary shares) ...
Nasdaq GlobeNewswire
28/05/2024

Cellectis Reports Financial Results for First Quarter 2024

• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca• Cash position of $143 million as of March 31, 2024 1 ; cash runway projection into 20262• Conference call and webcast scheduled for tomorrow, May 29, 2024 at 8:00AM ET / 2:00PM CET NEW YORK, May28, 2024(GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to...
Nasdaq GlobeNewswire
28/05/2024

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program…

New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic head and neck cancer (n=68) to be presented by Coordinating Investigator Colette Shen, MD, PhD, at ASCO 2024Following the ASCO presentation, Nanobiotix will host an investor event on Sunday, June 2 ndat 12:00 PM EDT / 6:00 PM CEST to review the presented results PARIS and CAMBRIDGE, Mass...
Nasdaq GlobeNewswire
28/05/2024

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young…

Among the more promising methods of tackling the issue is coming from the field of immunotherapies that help the body's immune system fight diseases, including cancer. One immunotherapy in particular that's gaining a lot of traction is pelareorep, the flagship asset of Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) — which gained its second FDA fast track designation 14 months ago. Among the more promising methods of tackling the issue is coming from the field of immunotherapies that help...
PR Newswire
28/05/2024

Groupe Casino: Completion of sale of Casino's stake in GreenYellow

Completion of sale of Casino's stake in GreenYellow Paris, 28 May 2024Casino Group confirms today the completion of the sale to Ardian and Bpifrance of its 10.15% residual stake in GreenYellow announced on 13 May 2024 ( link ) for net proceeds of EUR 46 million.Following this transaction, Casino Group no longer holds any stake in GreenYellow share capital. ***This press release has been prepared for information purposes only and should not be construed as a solicitation or offer...
Nasdaq GlobeNewswire
28/05/2024

Diabetic Kidney Disease Market Size to Worth USD 5.32 Bn By 2031

Market Dynamics: Market Dynamics : Rising geriatric population is one of the major drivers propelling the growth of the diabetic kidney disease market. As per estimates, by 2050 around 2 billion people globally will be aged 60 years and above. Elderly people are more prone to develop type 2 diabetes due to reduced immunity. Diabetes at an older age can further lead to kidney complications. Additionally, increasing incidence of obesity is also fueling the risk of diabetes, thereby augmenting...
PR Newswire
28/05/2024

Annual General Meeting of Ipsen S.A. held on 28 May 2024

All the resolutions submitted to the shareholders' vote have been adoptedPARIS, FRANCE, 28 May 2024 -The Annual General Meeting of Ipsen S.A. (Euronext: IPN; ADR: IPSEY) was held today at theSalons de l'Hôtel des Arts et Métiers, 9 bis, avenue d'Iéna, 75116 Paris (France), under the chairmanship of Mr. Marc de GARIDEL, Chairman of the Board of Directors, and in the presence of the members of the Board of Directors and the Group's Executive Leadership Team.The Annual General Meeting...
Nasdaq GlobeNewswire
28/05/2024

Concierge Medicine Market Size to Surpass USD 37.87 Bn By 2031

Market Dynamics: Market Dynamics : The concierge medicine market is driven by rising disposable incomes coupled with improving standards of living across the globe. As disposable incomes rise, people are able to afford better healthcare facilities such as concierge medicine. In addition, increasing burden of chronic diseases due to sedentary lifestyles and unhealthy diet is also fueling market growth. According to WHO, chronic diseases accounted for approximately 60% of all deaths...
PR Newswire
28/05/2024

SCENTAIR® BREAKS NEW GROUND WITH SUSTAINABLE FRAGRANCES & RECYCLABLE CARTRIDGES

The new line of Sustainable Fragrances is available across the business, accessible to both commercial clients globally and consumers in the United States. Businesses can improve customer experience while choosing a greener alternative by working directly with their ScentAir representative, while consumers can purchase the new eco-friendly fragrances directly from ScentAir's eCommerce store. The new line of Sustainable Fragrances is available across the business, accessible to both commercial...
PR Newswire
28/05/2024

Healthcare IT Market to be Worth $907.18 Billion by 2031 - Exclusive Report by…

Health information technology (HCIT) comprises various technologies that gather, store, analyze, and represent information for various areas in the healthcare sector. Over the years, the global healthcare IT industry has transitioned from the application of IT solutions from basic administrative functions to core clinical tasks. The increased amount of data gathered through patient records has now led to the deployment of advanced IT solutions in the healthcare sector. This includes the…
PR Newswire
28/05/2024

Stroke Diagnostics Market Size to Hit USD 5.32 Bn By 2031

Market Dynamics: Market Dynamics : The rising incidence of stroke around the world is a major factor driving the growth of the stroke diagnostics market. According to WHO, 15 million people suffer from stroke worldwide each year. Furthermore, advancements in diagnostic imaging technologies for stroke diagnosis are also boosting the market growth. Computed tomography (CT) scan and magnetic resonance imaging (MRI) have revolutionized stroke diagnosis by detecting occlusions and bleed with...
PR Newswire
28/05/2024

Tumor Ablation Market Worth $1.4 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258 Browse in-depth TOC on "Tumor Ablation Market" 146 - Tables 56 - Figures 192 - Pages Tumor Ablation Market Scope: Microwave ablation segment to register significant growth rate over the forecast period of 2024-2029. Based on the technology, the global market is...
PR Newswire
28/05/2024

Global Smart Pills Market to Surge at a CAGR of ~11% by 2030 | DelveInsight

Key Takeaways from the Smart Pills Market Report Key Takeaways from the Smart Pills Market Report To read more about the latest highlights related to the smart pills market, get a snapshot of the key highlights entailed in theGlobal Smart Pills Market Report Smart Pills Overview Smart pills, also known as digital pills or ingestible sensors, represent a breakthrough in medical technology by combining pharmaceuticals with digital monitoring capabilities. These pills are...
PR Newswire
28/05/2024
Altri  Comunicati